FDA Gives Clearance to 2 OTC Continuous Glucose Monitoring Systems
Continuous glucose monitoring systems offer timely biofeedback for patients with type 2 diabetes.
Source: pharmacytimes.com
Libre Rio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Libre Rio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Libre Rio Today - Breaking & Trending Today
FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin
The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release. The FDA cleared the Abbott Libre Rio for adults aged 18 years and older with type 2 diabetes. The OTC CGM is designed for adults who do not use insulin and who
Source: healio.com
FDA clears 2 Abbott OTC glucose monitors
Abbott Laboratories received U.S. FDA clearance for its Lingo and Libre Rio over-the-counter continuous glucose monitoring systems, enabling it to challenge Dexcom Inc. in this rapidly growing market. Dexcom received FDA clearance for its OTC Stela continuous glucose monitor in March.
Source: bioworld.com